Literature DB >> 3319503

Cephalosporins in surgery. Prophylaxis and therapy.

D W McEniry1, S L Gorbach.   

Abstract

Prophylactic antibiotics in surgery are intended to prevent morbidity and mortality, as well as to reduce the duration and cost of hospitalisation. The indications for prophylaxis, and its effectiveness, should be evaluated with these criteria in mind. The basis for antibiotic prophylaxis in surgery is either provision of an effective concentration of antibiotic in the tissue site at the time of potential contamination, or (primarily in the case of colorectal surgery) to reduce the inoculum of potentially contaminating bacteria. Cephalosporins are the antibiotics most widely used for prophylaxis in surgery, and have clearly been shown to reduce postoperative morbidity in vaginal hysterectomy, resection of head and neck cancers, vascular grafting, total joint replacement, repair of hip fractures, and high risk gastroduodenal surgery. They are probably also useful in cardiac surgery, abdominal hysterectomy, caesarean section, and colorectal surgery. For orthopaedic, cardiac, gynaecological, and gastroduodenal procedures it is important to select an antibiotic with proven clinical activity against Gram-positive organisms. For head and neck surgery, the spectrum of activity should also include oral anaerobes and Enterobacteriaceae. For biliary surgery an antibiotic effective against both Gram-positive and Gram-negative organisms may offer at least theoretical advantages, while for appendicectomy a cephamycin represents the most appropriate choice. In colorectal procedures, activity against B. fragilis is the major consideration in selecting an antibiotic for systemic prophylaxis. When intra-abdominal sepsis occurs following surgery, a potentially wide range of bacteria may be implicated, but in practice such infections are due to a small number of species, with B. fragilis most commonly implicated. The most useful cephalosporins in this setting are those active against both aerobic Gram-negative bacteria and anaerobes, especially B. fragilis. In practice, an aminoglycoside is often administered concomitantly. Importantly, prompt surgical treatment is the cornerstone of management of abdominal sepsis, and empirical antibiotic therapy should be adjusted as needed when culture and sensitivity tests become available.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319503     DOI: 10.2165/00003495-198700342-00016

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  120 in total

1.  Prophylactic use of cephazolin against wound sepsis after cholecystectomy.

Authors:  C J Strachan; J Black; S J Powis; T A Waterworth; R Wise; A R Wilkinson; D W Burdon; M Severn; B Mitra; H Norcott
Journal:  Br Med J       Date:  1977-05-14

2.  The reduction of surgical wound infections by prophylactic parenteral cephaloridine. A controlled clinical trial.

Authors:  C Evans; A V Pollock
Journal:  Br J Surg       Date:  1973-06       Impact factor: 6.939

3.  Clinical comparison of cefotaxime with gentamicin plus clindamycin in the treatment of peritonitis and other soft-tissue infections.

Authors:  H H Stone; E S Morris; C E Geheber; L D Kolb; W E Dunlop
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

4.  Antimicrobial prophylaxis for contaminated head and neck surgery.

Authors:  J T Johnson; E N Myers; P B Thearle; B A Sigler; V L Schramm
Journal:  Laryngoscope       Date:  1984-01       Impact factor: 3.325

5.  Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.

Authors:  R Wise; J M Andrews; G Danks
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

6.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

7.  Perforated and gangrenous appendicitis: an analysis of antibiotic failures.

Authors:  P N Heseltine; A E Yellin; M D Appleman; M A Gill; F C Chenella; J W Kern; T V Berne
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

8.  A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.

Authors:  F P Tally; K McGowan; J M Kellum; S L Gorbach; T F O'Donnell
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

9.  Cephalothin, cefoxitin, or metronidazole in elective colonic surgery? A single-blind randomized trial.

Authors:  G Panichi; A Pantosti; G Giunchi; F Tonelli; P D'Amicis; G Fegiz; P Gianfrilli Mastrantonio; I Luzzi; M E Grandolfi
Journal:  Dis Colon Rectum       Date:  1982 Nov-Dec       Impact factor: 4.585

10.  Antibiotic levels in infected and sterile subcutaneous abscesses in mice.

Authors:  K A Joiner; B R Lowe; J L Dzink; J G Bartlett
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

View more
  4 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

2.  Trends in orthopaedic antimicrobial prophylaxis in the UK between 2005 and 2011.

Authors:  R S Aujla; D J Bryson; A Gulihar; G J Taylor
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

Review 3.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Differential effects of different delivery methods on progression to severe postpartum hemorrhage between Chinese nulliparous and multiparous women: a retrospective cohort study.

Authors:  Chang Xu; Wanting Zhong; Qiang Fu; Li Yi; Yuqing Deng; Zhaohui Cheng; Xiaojun Lin; Miao Cai; Shilin Zhong; Manli Wang; Hongbing Tao; Haoling Xiong; Xin Jiang; Yun Chen
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-31       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.